Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients

[1] Pirson Y(1977)Long-term effect of HBs antigenemia on patient survival after renal transplantation N Engl J Med 296 194-196

[2] Alexandre GP(1999)Impact of hepatitis B and C virus on kidney transplantation outcome Hepatology 29 257-263

[3] Ypersele C(2002)Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation Clin Transplant 16 130-136

[4] Mathurin P(1988)Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients Gastroenterology 94 151-156

[5] Mouquet C(1987)Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies Transplantation 44 369-376

[6] Poynard T(1991)Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients Transplantation 51 391-396

[7] Sylla C(1996)The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection Transplantation 62 297-299

[8] Benalia H(1985)The impact of renal transplantation on the course of hepatitis B liver disease Transplantation 39 610-615

[9] Fretz C(2008)Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan Transplant Proc 40 2397-2399

[10] Breitenfeldt MK(2002)Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients Hepatology 36 1246-1252

[1] Pirson Y(1977)Long-term effect of HBs antigenemia on patient survival after renal transplantation N Engl J Med 296 194-196

[2] Alexandre GP(1999)Impact of hepatitis B and C virus on kidney transplantation outcome Hepatology 29 257-263

[3] Ypersele C(2002)Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation Clin Transplant 16 130-136

[4] Mathurin P(1988)Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients Gastroenterology 94 151-156

[5] Mouquet C(1987)Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies Transplantation 44 369-376

[6] Poynard T(1991)Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients Transplantation 51 391-396

[7] Sylla C(1996)The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection Transplantation 62 297-299

[8] Benalia H(1985)The impact of renal transplantation on the course of hepatitis B liver disease Transplantation 39 610-615

[9] Fretz C(2008)Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan Transplant Proc 40 2397-2399

[10] Breitenfeldt MK(2002)Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients Hepatology 36 1246-1252